Literature DB >> 23447641

Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?

Dorte Bek Folkvardsen1, Erik Svensson, Vibeke Ø Thomsen, Erik Michael Rasmussen, Didi Bang, Jim Werngren, Sven Hoffner, Doris Hillemann, Leen Rigouts.   

Abstract

Patients may harbor both drug-susceptible and -resistant bacteria, representing heteroresistance. We studied mixtures of isoniazid-resistant and -susceptible Mycobacterium tuberculosis strains. Conventional drug susceptibility testing was the most sensitive method of detection, whereas the line probe assay and sequencing were not able to detect the clinically relevant 1% proportion of resistant bacteria.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23447641      PMCID： PMC3647910          DOI： 10.1128/JCM.00472-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG.

Authors:  G Abate; S E Hoffner; V O Thomsen; H Miörner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-05       Impact factor: 3.267

2.  Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens.

Authors:  M Palaci; S Y Ueki; D N Sato; M A Da Silva Telles; M Curcio; E A Silva
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.

Authors:  H L David
Journal:  Appl Microbiol       Date:  1970-11

5.  Pyrosequencing for detection of lamivudine-resistant hepatitis B virus.

Authors:  Anna Lindström; Jacob Odeberg; Jan Albert
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 6.  The mechanism of isoniazid killing: clarity through the scope of genetics.

Authors:  Catherine Vilchèze; William R Jacobs
Journal:  Annu Rev Microbiol       Date:  2007       Impact factor: 15.500

7.  Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates.

Authors:  R Vijdea; M Stegger; A Sosnovskaja; A B Andersen; V Ø Thomsen; D Bang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-05       Impact factor: 3.267

8.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

9.  Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.

Authors:  B Heym; N Honoré; C Truffot-Pernot; A Banerjee; C Schurra; W R Jacobs; J D van Embden; J H Grosset; S T Cole
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

10.  European union standards for tuberculosis care.

Authors:  G B Migliori; J P Zellweger; I Abubakar; E Ibraim; J A Caminero; G De Vries; L D'Ambrosio; R Centis; G Sotgiu; O Menegale; K Kliiman; T Aksamit; D M Cirillo; M Danilovits; M Dara; K Dheda; A T Dinh-Xuan; H Kluge; C Lange; V Leimane; R Loddenkemper; L P Nicod; M C Raviglione; A Spanevello; V Ø Thomsen; M Villar; M Wanlin; J A Wedzicha; A Zumla; F Blasi; E Huitric; A Sandgren; D Manissero
Journal:  Eur Respir J       Date:  2012-04       Impact factor: 16.671
  10 in total
  30 in total

1.  Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.

Authors:  N Bablishvili; N Tukvadze; E Shashkina; B Mathema; N R Gandhi; H M Blumberg; R R Kempker
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis.

Authors:  Siavash J Valafar
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

3.  Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?

Authors:  Jim Werngren; Erik Alm; Mikael Mansjö
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

4.  Detection of heteroresistant Mycobacterium tuberculosis by pyrosequencing.

Authors:  Anna Engström; Sven Hoffner; Pontus Juréen
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

5.  Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.

Authors:  John Z Metcalfe; Elizabeth Streicher; Grant Theron; Rebecca E Colman; Christopher Allender; Darrin Lemmer; Rob Warren; David M Engelthaler
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

6.  Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.

Authors:  Florence Brossier; Anne Pham; Christine Bernard; Alexandra Aubry; Vincent Jarlier; Nicolas Veziris; Wladimir Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

7.  Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis.

Authors:  Siyu Hu; Guoli Li; Hui Li; Xiaoli Liu; Jianjun Niu; Shengmao Quan; Feng Wang; Huixin Wen; Ye Xu; Qingge Li
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

8.  Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.

Authors:  Syed Beenish Rufai; Parveen Kumar; Amit Singh; Suneel Prajapati; Veena Balooni; Sarman Singh
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

9.  Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene.

Authors:  Z Zhang; J Lu; Y Wang; Y Pang; Y Zhao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-26       Impact factor: 3.267

10.  Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay.

Authors:  Bin Liang; Yaoju Tan; Zi Li; Xueshan Tian; Chen Du; Hui Li; Guoli Li; Xiangyang Yao; Zhongan Wang; Ye Xu; Qingge Li
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.